Experience with sorafenib in the treatment of advanced renal cell carcinoma

Experience with sorafenib in the treatment of advanced renal cell carcinoma

The molecular-targeted agent sorafenib is the first anticancer agent able to slow the progression of advanced/metastatic renal cell carcinoma, a tumor that was formerly refractory to conventional therapy. Experience from everyday clinical practice and investigations exploring the suitability of this...

Full description

Bibliographic Details
Main Authors:	Giuseppe Procopio, Elena Verzoni, Isabella Testa, Nicola Nicolai, Roberto Salvioni, Filippo DeBraud
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-12-01
Series:	Therapeutic Advances in Urology
Online Access:	https://doi.org/10.1177/1756287212457216

Similar Items

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib
by: Paolo Grassi, et al.
Published: (2015-04-01)

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
by: Elisa Zanardi, et al.
Published: (2015-06-01)

Targeted treatments in advanced renal cell carcinoma: focus on axitinib
by: Verzoni E, et al.
Published: (2014-03-01)

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
by: Alessia Mennitto, et al.
Published: (2016-10-01)

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
by: Grassi P, et al.
Published: (2016-07-01)

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
by: Alessandra Raimondi, et al.
Published: (2020-08-01)

Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
by: Darawan Rinchai, et al.
Published: (2021-06-01)

Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma
by: Changfu Liu, et al.
Published: (2019-01-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Advanced kidney carcinoma: decision paths and therapeutic perspectives
by: Valentina Da Prat, et al.
Published: (2014-09-01)

Response to targeted therapy in urachal adenocarcinoma
by: Isabella Testa, et al.
Published: (2014-12-01)

Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
by: Omar Abdel-Rahman, et al.
Published: (2014-03-01)

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
by: Sangheun Lee, et al.
Published: (2013-01-01)

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors
by: Elena Verzoni, et al.
Published: (2016-09-01)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
by: Hitomi Takada, et al.
Published: (2018-01-01)

Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre
by: Mohit Saxena, et al.
Published: (2018-07-01)

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer
by: Kyung Hwa Choi, et al.
Published: (2019-02-01)

A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting.
by: Mayer N Fishman, et al.
Published: (2015-01-01)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
by: Qinqin Liu, et al.
Published: (2021-10-01)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
by: Song-Fong Huang, et al.
Published: (2022-09-01)

Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience
by: José Presa Ramos, et al.
Published: (2023-06-01)

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
by: Joon-Il Choi, et al.
Published: (2014-06-01)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2019-05-01)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
by: Imane El Dika, et al.
Published: (2020-10-01)

Second-line treatment in renal cell carcinoma: clinical experience and decision making
by: Valentina Guadalupi, et al.
Published: (2021-06-01)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
by: Ryu Sasaki, MD, PhD, et al.
Published: (2022-05-01)

Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma
by: Daniele Alesini, et al.
Published: (2015-10-01)

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
by: Paolo Grassi, et al.
Published: (2016-01-01)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
by: Xinye Qian, MD, PhD
Published: (2023-03-01)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
by: Hsu CH, et al.
Published: (2014-06-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
by: Guilherme Nader Marta, et al.
Published: (2021-01-01)

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
by: Qu Xu-Dong, et al.
Published: (2012-06-01)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Junji Furuse
Published: (2008-11-01)

Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan
by: Chan KM, et al.
Published: (2019-01-01)

Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
by: Adi Kartolo, et al.
Published: (2021-08-01)

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)
by: Marco Maruzzo, et al.
Published: (2021-11-01)

Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy
by: Bottiglieri A, et al.
Published: (2022-10-01)